Skip to main content
Caplight Logo









Encapsulate

Encapsulate

Private
Farmington, ConnecticutHealthcare & Life Scienceshttps://encapsulate.bio/

Last Round

Grant

Jul 1, 2025

Total Funding Raised

$5.35M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Encapsulate is a biotechnology company that develops automated tumor-on-a-chip systems to provide personalized cancer therapy recommendations by testing treatments on patient-derived microtumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

tumor-on-a-chipprecision oncologyorgan-on-a-chipdrug screeningmicrofluidicspersonalized medicinepatient-derived microtumorspre-clinical researchcancer diagnosticsbiotech lab automationmicrogravity researchlab-on-a-chip3D cell culturechemotherapy response testingbiochip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Encapsulate Comparables

Compare Encapsulate with similar companies based on industry and business-model similarity.

Encapsulate comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Xilis
86%
PreComb Therapeutics
83%
Kiyatec
81%

Encapsulate Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 1, 2025
GrantJun 15, 2025
SeedNov 19, 2024
GrantNov 18, 2024
GrantMar 15, 2023
Grant
May 15, 2022

Key People

Founding team and executive leadership

Leila Daneshmandi

Co-Founder And COO

Founding Team

Armin Rad

CEO, Co-Founder

Founding Team

Encapsulate Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 18, 2026

    Grew 23% QoQ, from 13 to 16 employees.

  • Jul 8, 2025

    Received $3.63M from NASA for a microgravity cancer device.

Encapsulate Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Encapsulate Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Encapsulate's valuation, stock price, and market status.

Firmographic Details

HeadquartersFarmington, Connecticut
Employee Range16
Year Founded2019
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?